Overview and future prospects.
At present, resection affords highly selected patients with limited liver cancer their only choice for cure. Palliation with currently available agents and techniques often is not successful, but recent advances promise a brighter future.
Foster
J H
JH
Department of Surgery, University of Connecticut School of Medicine, Farmington, Connecticut, USA.
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D010478:Chemotherapy, Cancer, Regional Perfusion; D002985:Clinical Protocols; D003131:Combined Modality Therapy; D005544:Forecasting; D006498:Hepatectomy; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy / Q000556:secondary / Q000601:surgery / Q000628:therapy*; D010166:Palliative Care; D018579:Patient Selection
D000970:Antineoplastic Agents